Stock Events

Stock Events

Spyre Therapeutics (3920.F) Q1 2026 Earnings

19FebConfirmed

Q2 2025

Q3 2025

Q4 2025

Q1 2026

-0.75

-0.54

-0.34

-0.13

Details

Expected EPS

-0.6023413953000001

Actual EPS

-0.59451

Surprise EPS

0.01

Surprise Percent

+1.3%

Description

Spyre Therapeutics (3920.F) has reported earnings of -0.59451 per share for Q1 2026.

0 Comments

Share your thoughts

Get the Stock Events App

Sign up for a Stock Events account to create your own watchlists and track your portfolio or dividends.